Patents by Inventor Demetrios MANEKAS

Demetrios MANEKAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20240124592
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Application
    Filed: July 26, 2023
    Publication date: April 18, 2024
    Applicant: Bristol-Myers Squibb Company
    Inventors: Demetrios MANEKAS, Joseph GROSSO, Jeffrey A. ANDERSON
  • METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20200190198
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Application
    Filed: December 5, 2019
    Publication date: June 18, 2020
    Applicant: Bristol-Myers Squibb Company
    Inventors: Demetrios MANEKAS, Joseph GROSSO, Jeffrey A. ANDERSON
  • Method of treating cancer using immune checkpoint inhibitor
    Patent number: 10544224
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: January 28, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Demetrios Manekas, Joseph Grosso, Jeffrey Anderson
  • METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20170037132
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Application
    Filed: July 14, 2016
    Publication date: February 9, 2017
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Demetrios MANEKAS, Joseph Grosso, Jeffrey Anderson